FDA Approves Tablet Formulation of Zanubrutinib for All Indications
Pharmacy Times
JUNE 11, 2025
Package insert. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/[link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. FDA approves tablet formulation of BeOne's BRUKINSA for all approved indications. News Release.
Let's personalize your content